GA
Gajanand Agrawal
About Gajanand Agrawal
Data last updated:
Gajanand Agrawal is a Director at Unidrug Innovative Pharma Technologies Limited (since 2018). The company operates in Pharma. Unidrug Innovative Pharma Technologies Limited reported revenue of ₹44.46 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unidrug Innovative Pharma Technologies Limited U85120MP1987PLC003875 | Director | 20 Sep 2018 | 1987 | ₹44.46 Cr (FY 2025) | Active |
Board colleagues of Gajanand Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bharat Jain | 00035708 | Unidrug Innovative Pharma Technologies Limited | Director |
| Jainesh Jain | 02355170 | Unidrug Innovative Pharma Technologies Limited | Managing Director |
| Mahesh Nabar | Unidrug Innovative Pharma Technologies Limited | Cfo | |
| Varsha Jain | 00255907 | Unidrug Innovative Pharma Technologies Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gajanand Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gajanand Agrawal
Gajanand Agrawal currently holds 1 directorship: Unidrug Innovative Pharma Technologies Limited (Director, since 20 Sep 2018, revenue ₹44.46 Cr (FY 2025)).
Gajanand Agrawal was first appointed on 20 Sep 2018 as Director at Unidrug Innovative Pharma Technologies Limited.
The current boards of Gajanand Agrawal's companies include Bharat Jain (Unidrug Innovative Pharma Technologies Limited), Jainesh Jain (Unidrug Innovative Pharma Technologies Limited), Mahesh Nabar (Unidrug Innovative Pharma Technologies Limited), Varsha Jain (Unidrug Innovative Pharma Technologies Limited).